NBC New York: Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and ...
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Eli Lilly on Tuesday said its daily obesity pill succeeded in another late-stage trial, helping patients with obesity and Type 2 diabetes lose weight and lower their blood sugar levels. The company ...
WWNO: The FDA approves a new obesity pill, giving patients another option
MSN: Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%
Eli Lilly said its daily obesity pill met the company's goals in the first of several closely watched late-stage trials. The pill helped Type 2 diabetes patients lower their blood sugar and body ...
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%
CNBC: Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
Novo Nordisk's new Wegovy GLP-1 pill appears to be expanding the obesity treatment market, drawing in new patients rather than converting existing ones from injections. CNBC spoke with five U.S.
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
NPR: The FDA approves a new obesity pill, giving patients another option
Stay on top of the latest developments related to patient education. Browse the AMA’s patient education resources, full of information and tools that physicians can share with their patients, including educational handouts for patients and other patient education materials.
For this installment, three AMA members took time to discuss what doctors wish patients knew about the potentially harmful effects of social media. They are: Nusheen Ameenuddin, MD, MPH, a pediatrician in Rochester, Minnesota, and chair of the American Academy of Pediatrics Council on Communications and Media.
The discussion was moderated by William B. Jordan, MD, MPH, who is senior director of equity policy and transformation at the AMA Center for Health Equity. Panelists examined the quality of care older-adult physicians provide, how age-related biases affect older-adult physicians, and how ageism affects patients’ care experience.
The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines and how to take charge of their health through preventive care.
Getting patients to make healthy lifestyle choices ranks high on every physician’s professional wish list. But realistically accomplishing this goal requires care teams to zero in on what really patients really want.
The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines. Three physicians took time to discuss what doctors wish patients knew about vitamins and nutritional supplements. They are: Pieter Cohen, MD, an internist in Somerville ...
Patients with Meniere’s disease “will have episodes of vertigo, usually lasting half an hour to a couple of hours that can be very intense and incapacitating and unpredictable, but they almost always have a symptom of hearing loss or ringing in their ear either immediately before or during the onset of vertigo,” he said.
Public Health Prevention & Wellness What doctors wish patients knew about iron deficiency One in three women under 50 is iron deficient, affecting about 10 million people in the U.S. Two physicians discuss iron deficiency and how to address it.
The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines and how to take charge of their health through preventive care. For this installment, two AMA members shared what doctors wish patients knew about sodium consumption. They are:
Most patients are diagnosed at a far less treatable, later stage of the disease. And with about 20% of lung cancer deaths preventable, evidence-based screening recommendations for high-risk patients offer the best hope to catch the disease early and provide the best chance for effective treatment. A medical oncologist shares more.
Patient perspectives around data privacy The American Medical Association partnered with Savvy Cooperative, a patient-owned source of health care insights, to survey 1,000 patients across the U.S. on their perspectives toward the privacy of their medical information. We found that by understanding the patient perspective on data privacy, industry and government can better act to help patients ...
Practice Management Digital Make sure health AI works for patients and physicians The AMA House of Delegates outlines steps that must be taken to ensure the technology remains an asset, even as health AI keeps evolving.
The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines. Anjali N. Patel, DO, a cognitive neurologist at the Atlantic Neuroscience Institute at Overlook Medical Center, took time to discuss what to know about Alzheimer’s disease.
Knowing how and when to use the patient portal can help improve patients’ outcomes and could lighten the workloads that contribute to physician burnout. The AMA’s What Doctors Wish Patients Knew ™ series provides physicians with a platform to share what they want patients to understand about today’s health care headlines.
The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines.
CNBC: 2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market
In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster injections ...
2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market
CNBC: Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval